Growth hormone safe for infants with chronic kidney failure

Jun 03, 2010

Infants with chronic renal failure (CRF) grow slowly, a problem that usually improves with aggressive nutritional therapy. When it doesn't, growth hormone is a safe and effective treatment to promote growth, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

"Early treatment with growth hormone improves growth retardation and without short-term undesirable effects," comments Fernando Santos, MD, PhD (Hospital Universitario Central de Asturias, Oviedo, Spain).

The Spanish-Portuguese multicenter collaborative study included 16 infants with CRF who had continued growth retardation despite nutritional therapy. All infants were receiving dialysis or other conservative treatments for their .

One group of infants received growth hormone while the other did not. During the yearlong study, infants treated with growth hormone grew an average of 5.7 inches, compared to 3.7 inches in those who did not receive growth hormone.

Equally important, growth hormone caused no harmful effects such as early bone maturation, progression of kidney disease, or . Several key indicators of nutrition and bone growth were similar between groups.

Some infants with CRF do not grow, despite receiving good nutrition and treatment to control other factors that can lead to growth problems. The new results show that, for these uncommon cases, growth hormone therapy can be effective. "Growth hormone is an additional tool to avoid aggravation of growth impairment in this group of patients," says Santos.

In some countries—including Spain and Portugal—growth hormone is not approved for use in children less than two years old. By that time, children with CRF may already have an important delay in growth, according to Santos.

Even in countries where is approved for the treatment of growth failure in young children (including the United States), doctors and parents may be reluctant to use it. "Our study supports early treatment with GH in those infants with CRF who remain growth retarded after achieving good clinical, metabolic and nutritional control," Santos and coauthors conclude.

Santos adds that further follow-up would provide interesting data on the long-term evolution of growth and on the progression of kidney failure.

Explore further: Global Ebola toll rises to 5,689: WHO

More information: "Improvement in Growth After 1 Year of Growth Hormone Therapy in Well-Nourished Infants with Growth Retardation Secondary to Chronic Renal Failure: Results of a Multicenter, Controlled, Randomized, Open Clinical Trial," doi:10.2215/CJN.07791109

add to favorites email to friend print save as pdf

Related Stories

Hormone therapy helps short children grow up

Nov 06, 2008

Growth hormone treatment may significantly increase final height in children diagnosed with short stature, even in cases where the child is not growth hormone deficient, according to a new study accepted for publication in ...

Predicting growth hormone treatment success

Dec 12, 2007

Growth hormone treatments work better on some children than on others, but judging which candidates will gain those vital inches in height is no simple task. Now researchers have developed a new mathematical model which predicts ...

Does growth hormone drug slow Alzheimer's disease?

Nov 17, 2008

A new study shows that a drug that increases the release of growth hormone failed to slow the rate of progression of Alzheimer's disease in humans. The new research is published in the November 18, 2008, print issue of Neurology, the me ...

Recommended for you

Global Ebola toll rises to 5,689: WHO

2 hours ago

The World Health Organization said Thursday that the global death toll from the Ebola virus had increased to 5,689 out of a total of 15,935 cases of infection, mainly in western Africa.

Ebola vaccine promising in first human trials

12 hours ago

Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

At one month, US Ebola monitors finding no cases

15 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.